Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...
Giant retinal tears (GRTs) are rare and challenging complications of rhegmatogenous retinal detachment (RRD) that necessitate intricate surgical management. So, this study aimed to ...
A device that delivers a tyrosine kinase inhibitor can improve visual acuity and central subfield thickness in patients with diabetic macular edema, a 16-week phase 2 trial shows. Patients with ...